Concord Wealth Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-25
Closed -$3.21K – 1262
2022
Q4
$3.21K Buy
+25
New +$3.23K ﹤0.01% 853
2022
Q3
– Sell
-25
Closed -$4K – 1247
2022
Q2
$4K Sell
25
-47
-65% -$6.77K ﹤0.01% 908
2022
Q1
$10K Buy
72
+8
+13% +$1.08K ﹤0.01% 792
2021
Q4
$10K Buy
64
+59
+1,180% +$9.88K ﹤0.01% 795
2021
Q3
$1K Buy
+5
New +$778 ﹤0.01% 882
2021
Q1
– Sell
-5
Closed -$1K – 1078
2020
Q4
$1K Buy
+5
New +$932 ﹤0.01% 671

Other funds holding SGEN

Concord Wealth Partners's SGEN Position: Q1 2023 in Review

Concord Wealth Partners sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 25 shares — an estimated $3.21K sold.

Concord Wealth Partners first reported a position in SGEN in Q4 2020 and held it in 6 quarters. The position peaked at $10K in Q1 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

  • Concord Wealth Partners reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Concord Wealth Partners sold 25 Seagen Inc. Common Stock shares in Q1 2023, an estimated $3.21K.
  • Concord Wealth Partners first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Concord Wealth Partners's Seagen Inc. Common Stock position peaked at $10K in Q1 2022.
  • 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on Concord Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.